Skip to main content
. 2020 Feb 28;21(5):1650. doi: 10.3390/ijms21051650
CTEPH Chronic thromboembolic pulmonary hypertension
DVT Deep vein thrombosis
IVC Inferior vena cava
MMP Matrix metalloproteinase
PAI-1 Plasminogen activator inhibitor type I
PE Pulmonary embolism
PTS Post-thrombotic syndrome
TEM Effector memory T cells
tPA Tissue-type plasminogen activator
uPA Urokinase-type plasminogen activator